menu
    • menu
    [{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"BELGIUM","productType":"Protein","year":"2023","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ BioTeSys GmbH"},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"KGK Science","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"BELGIUM","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ KGK Science","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ KGK Science"},{"orgOrder":0,"company":"Shan May Yong","sponsor":"Chang Gung Memorial Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"","productType":"Protein","year":"2020","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase I","graph3":"Shan May Yong","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Shan May Yong \/ Chang Gung Memorial Hospital","highestDevelopmentStatusID":"6","companyTruncated":"Shan May Yong \/ Chang Gung Memorial Hospital"},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"Nutrasource","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"BELGIUM","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ Nutrasource","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ Nutrasource"},{"orgOrder":0,"company":"Rousselot BVBA","sponsor":"BioTeSys GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"BELGIUM","productType":"Protein","year":"2025","type":"Inapplicable","leadProduct":"Collagen Peptide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Rousselot BVBA","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Rousselot BVBA \/ BioTeSys GmbH","highestDevelopmentStatusID":"1","companyTruncated":"Rousselot BVBA \/ BioTeSys GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals for Collagen Peptide

    Menu

    Collagen Peptide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake

                            Details : Collagen Hydrolysate is a Protein drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            September 26, 2025

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : KGK Science

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of Nextida GC-B on Glycemic Control in Normoglycemic & Prediabetic Adults

                            Details : Collagen Hydrolysate is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of unspecified medical condition.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            August 29, 2025

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : KGK Science

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Gastroenterology

                            Study Phase : Undisclosed

                            Sponsor : Nutrasource

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            To Assess the Effect of Collagen on Gastrointestinal Discomfort in Healthy Adults With Gastrointestinal Sympto...

                            Details : Collagen Peptide is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastrointestinal Diseases.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            April 22, 2025

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Gastroenterology

                            Highest Development Status : Undisclosed

                            Sponsor : Nutrasource

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Rousselot BVBA

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects

                            Details : Collagen Hydrolysate is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Prediabetic State.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            June 05, 2023

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : BioTeSys GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            Shan May Yong

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed

                            Shan May Yong

                            Country arrow
                            AIChE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase I

                            Sponsor : Chang Gung Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Effects of Chicken Extract and Collagen on Mobility

                            Details : Collagen Hydrolysate is a Protein drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Protein

                            Upfront Cash : Inapplicable

                            July 23, 2020

                            Lead Product(s) : Collagen Peptide

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase I

                            Sponsor : Chang Gung Memorial Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth